| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormalities of fibrinolytic parameters in patients with myeloproliferative diseases
|
Lanir, N.
|
|
1992
|
|
3 |
p. 183-186
4 p.
|
artikel
|
| 2 |
A comparison of cultured cells with other promoters of tissue plasminogen activator kinetics
|
Longstaff, C.
|
|
1995
|
|
3 |
p. 178-187
10 p.
|
artikel
|
| 3 |
A comparison of fibrinolytic capacity and response to TNF-α stimulation in the cultured endothelial cell lines ECV 304 and EA.hy 926
|
Martin, N.B.
|
|
1994
|
|
3 |
p. 147-155
9 p.
|
artikel
|
| 4 |
Activated protein C: Antithrombotic properties and influence on fibrinolysis in an animal model
|
Römisch, J.
|
|
1991
|
|
3 |
p. 191-196
6 p.
|
artikel
|
| 5 |
Activation of pro-urokinase by cathepsin G in the presence of glucosaminoglycans
|
Drag, B.
|
|
1994
|
|
3 |
p. 192-199
8 p.
|
artikel
|
| 6 |
Acute effects of moderate alcohol consumption on fibrinolytic factors in healthy middle-aged men
|
Veenstra, J.
|
|
1993
|
|
3 |
p. 177-182
6 p.
|
artikel
|
| 7 |
Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene
|
Falk, G.
|
|
1995
|
|
3 |
p. 170-174
5 p.
|
artikel
|
| 8 |
A monoclonal antibody to tissue plasminogen activator with affinity for the Kringle regions
|
Norrman, B.A.
|
|
1987
|
|
3 |
p. 135-142
8 p.
|
artikel
|
| 9 |
A new kit for the determination of tissue plasminogen activator and its inhibitor in blood
|
Nilsson, K.
|
|
1987
|
|
3 |
p. 163-168
6 p.
|
artikel
|
| 10 |
A non-catalytic, human urokinase plasminogen activator derivative produced by mouse cells has full receptor binding activity
|
Pedersen, N.
|
|
1991
|
|
3 |
p. 155-164
10 p.
|
artikel
|
| 11 |
Anti-streptokinase (SK) IgG remains low following local SK-therapy compared to intravenous coronary thrombolysis with SK
|
Breuning, L.
|
|
1994
|
|
3 |
p. 189-191
3 p.
|
artikel
|
| 12 |
Assessment of coagulation and fibrinolysis in synovial fluid of rheumatoid arthritis patients
|
Carmassi, F.
|
|
1994
|
|
3 |
p. 162-171
10 p.
|
artikel
|
| 13 |
A zymogenic tissue plasminogen activator variant: The Phe305→ His mutation suppresses fibrin(ogen) stimulated plasminogen activation by one chain t-PA
|
Higgins, D.L.
|
|
1992
|
|
3 |
p. 161-166
6 p.
|
artikel
|
| 14 |
Biochemical properties of variant plasminogens associated with thrombophilia: Defective binding and activation of variant plasminogens on the surface of monocytoid U937 cells
|
Kozlowski, K.A.
|
|
1994
|
|
3 |
p. 135-146
12 p.
|
artikel
|
| 15 |
Blood, textbook of haematology
|
Walker, I.D.
|
|
1988
|
|
3 |
p. 181-
1 p.
|
artikel
|
| 16 |
Can coronary thrombolysis meet the challenge of primary angioplasty?
|
de Bono, D.
|
|
1996
|
|
3 |
p. 137-142
6 p.
|
artikel
|
| 17 |
Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids
|
Krause, J.
|
|
1988
|
|
3 |
p. 133-142
10 p.
|
artikel
|
| 18 |
Characterisation of fibronectin fragments and plasminogen activators released by RSV-transformed cells
|
De Petro, G.
|
|
1987
|
|
3 |
p. 183-187
5 p.
|
artikel
|
| 19 |
Characterisation of rt-PA I276G, a recombinant human tissue-type plasminogen activator mutant with altered plasmin cleavage site
|
Lijnen, H.R.
|
|
1992
|
|
3 |
p. 149-159
11 p.
|
artikel
|
| 20 |
Characterization of nattokinase-degraded products from human fibrinogen or cross-linked fibrin
|
Fujita, M.
|
|
1995
|
|
3 |
p. 157-164
8 p.
|
artikel
|
| 21 |
Characterization of receptors interacting specifically with the B-chain of tissue plasminogen activator on endothelial cells
|
Cheng, X.-F.
|
|
1996
|
|
3 |
p. 167-175
9 p.
|
artikel
|
| 22 |
Comparison of fibrinolytic and amidolytic methods for the measurement of streptokinase pharmacokinetics in patients with acute myocardial infarction
|
Fears, R.
|
|
1989
|
|
3 |
p. 175-181
7 p.
|
artikel
|
| 23 |
Composition of emboli influences the efficacy of thrombolysis with rt-PA in a rat stroke model
|
Overgaard, K.
|
|
1993
|
|
3 |
p. 141-148
8 p.
|
artikel
|
| 24 |
Congenital plasminogen deficiency with an abnormal plasminogen: Frankfurt II, dysplasminogenaemia-hypoplasminogenaemia
|
Robbins, K.C.
|
|
1991
|
|
3 |
p. 145-153
9 p.
|
artikel
|
| 25 |
Conjunctive antithrombotic and thrombolytic therapy for acute myocardial infarction
|
Rapold, H.J.
|
|
1992
|
|
3 |
p. 137-140
4 p.
|
artikel
|
| 26 |
Consumption of reduced-fat products, haemostatic parameters and oral glucose tolerance test
|
Velthuis-te Wierik, E.J.M.
|
|
1996
|
|
3 |
p. 159-166
8 p.
|
artikel
|
| 27 |
Degradation products of fibrin and of fibrinogen in synovial fluid and in plasma of patients with rheumatoid arthritis
|
Jespersen, J.
|
|
1989
|
|
3 |
p. 183-186
4 p.
|
artikel
|
| 28 |
Depression of plasminogen activator activity during pregnancy by the placental inhibitor PAI 2
|
Lecander, I.
|
|
1988
|
|
3 |
p. 165-167
3 p.
|
artikel
|
| 29 |
Detection of reperfusion within 1 hour after coronary recanalisation by analysis of isoforms of the MM creatine kinase isoenzyme in plasma
|
Seacord, L.M.
|
|
1988
|
|
3 |
p. 151-156
6 p.
|
artikel
|
| 30 |
Different fibrinolytic potential in cultured human adult and umbilical vein endothelial cells
|
Arnman, V.
|
|
1993
|
|
3 |
p. 165-170
6 p.
|
artikel
|
| 31 |
Diminished release of tissue plasminogen activator during venous occlusion in manual workers
|
Stegnar, M.
|
|
1988
|
|
3 |
p. 175-179
5 p.
|
artikel
|
| 32 |
Distribution and pharmacokinetics of active recombinant plasminogen activator inhibitor-1 in the rat and rabbit
|
Racanelli, A.L.
|
|
1992
|
|
3 |
p. 187-191
5 p.
|
artikel
|
| 33 |
Divergent effect of n,n-dimethylformamide on the expression of urokinase and its receptor
|
Hollas, W.
|
|
1993
|
|
3 |
p. 149-157
9 p.
|
artikel
|
| 34 |
Dr G. V. Bashkov 1958–1995
|
|
|
1995
|
|
3 |
p. 199-
1 p.
|
artikel
|
| 35 |
Effect of deletion of epidermal growth factor-like domain on plasma clearance of pro-urokinase
|
Hiramatsu, R.
|
|
1989
|
|
3 |
p. 147-151
5 p.
|
artikel
|
| 36 |
Effect of different dietary induced hyperlipaemias on rat plasma fibrinolytic components
|
Padró, T.
|
|
1990
|
|
3 |
p. 161-167
7 p.
|
artikel
|
| 37 |
Effect of recombinant tissue-type plasminogen activator on ten platelet membrane glycoproteins
|
Ambrosi, P.
|
|
1992
|
|
3 |
p. 193-197
5 p.
|
artikel
|
| 38 |
Effects of an oral antidiabetic drug (gliclazide) on inhibition of coagulation and fibrinolysis studied in insulin-treated diabetic patients (type I)
|
Gram, J.
|
|
1989
|
|
3 |
p. 153-158
6 p.
|
artikel
|
| 39 |
Effects of the novel recombinant plasminogen activator BM 06.022 on human platelet aggregation in vitro
|
Martin, U.
|
|
1993
|
|
3 |
p. 203-210
8 p.
|
artikel
|
| 40 |
Enhancement of recombinant tissue plasminogen activator-induced reperfusion by recombinant tick anticoagulant peptide, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis
|
Mellott, M.J.
|
|
1993
|
|
3 |
p. 195-202
8 p.
|
artikel
|
| 41 |
Enzymatic properties of t-PA/α 2-macroglobulin complexes
|
Wiman, B.
|
|
1991
|
|
3 |
p. 181-186
6 p.
|
artikel
|
| 42 |
Erratum
|
|
|
1994
|
|
3 |
p. 202-
1 p.
|
artikel
|
| 43 |
Expression and characterisation of finger protease (FP); a mutant tissue-type plasminogen activator (t-PA) with improved pharmacokinetics
|
Trill, J.J.
|
|
1990
|
|
3 |
p. 131-140
10 p.
|
artikel
|
| 44 |
Expression of a human PAI-1 fusion peptide in E. coli and its immunochemical characterization
|
Swiatkowska, M.
|
|
1994
|
|
3 |
p. 177-181
5 p.
|
artikel
|
| 45 |
Fibrinolysis and risk of coronary artery disease
|
Juhan-Vague, I.
|
|
1996
|
|
3 |
p. 127-136
10 p.
|
artikel
|
| 46 |
Fibrinolysis during major abdominal surgery
|
Johnson, E.J.
|
|
1990
|
|
3 |
p. 147-151
5 p.
|
artikel
|
| 47 |
Fibrinolytic behaviour during experimental haemorrhagic shock
|
Aguiar Andrade, J.
|
|
1992
|
|
3 |
p. 199-202
4 p.
|
artikel
|
| 48 |
Fibrinolytic changes in malignant ascites
|
Oh, D.
|
|
1994
|
|
3 |
p. 156-161
6 p.
|
artikel
|
| 49 |
Fibrinolytic components in individual consecutive plasma samples during normal pregnancy
|
Lindoff, C.
|
|
1993
|
|
3 |
p. 190-194
5 p.
|
artikel
|
| 50 |
Fibrinolytic properties of staphylokinase mutants obtained by ‘clustered charge-to-alanine’ mutagenesis
|
Lijnen, H.R.
|
|
1996
|
|
3 |
p. 177-182
6 p.
|
artikel
|
| 51 |
Fibrinolytic response in malignancy
|
Páramo, J.A.
|
|
1987
|
|
3 |
p. 195-199
5 p.
|
artikel
|
| 52 |
Fundamental and clinical fibrinolysis
|
Davidson, J.F.
|
|
1988
|
|
3 |
p. 181-
1 p.
|
artikel
|
| 53 |
Haemostasis in patients with acute myeloid leukaemia treated with intermediate dose of cytosine arabinoside and mitoxantrone: the influence of chemotherapy, infection and remission status on haemostasis
|
Cetkovský, P.
|
|
1995
|
|
3 |
p. 165-169
5 p.
|
artikel
|
| 54 |
Heparin as an hyperbolic modulator of plasminogen activation by t-PA
|
Pirie-Shepherd, S.R.
|
|
1994
|
|
3 |
p. 182-188
7 p.
|
artikel
|
| 55 |
Importance of platelets in the process leading to PAI-1 increase following endotoxaemia in vivo
|
Bernat, A.
|
|
1995
|
|
3 |
p. 196-198
3 p.
|
artikel
|
| 56 |
Interactions between pharmacologic concentrations of plasminogen activators and platelets
|
Fry, E.T.A.
|
|
1989
|
|
3 |
p. 127-136
10 p.
|
artikel
|
| 57 |
Lipoprotein (a) does not influence hyperfibrinolysis in patients with liver cirrhosis
|
Alessandri, C.
|
|
1995
|
|
3 |
p. 133-138
6 p.
|
artikel
|
| 58 |
Lipoprotein (a): The link between impaired fibrinolysis and atherosclerosis
|
Edelberg, J.M.
|
|
1991
|
|
3 |
p. 135-143
9 p.
|
artikel
|
| 59 |
Little relationship of plasminogen activator inhibitor (PAI-1) with complications of insulin-dependent diabetes mellitus: Pittsburgh epidemiology of diabetes complications study
|
Maser, R.E.
|
|
1995
|
|
3 |
p. 139-144
6 p.
|
artikel
|
| 60 |
Mutants of human tissue-type plasminogen activator (t-PA): Structural aspects and functional properties
|
Pannekoek, H.
|
|
1988
|
|
3 |
p. 123-132
10 p.
|
artikel
|
| 61 |
Myocardial tissue salvage by coronary thrombolysis with rt-PA: Absence of occlusion/reperfusion injury
|
Oliver Jr., W.
|
|
1987
|
|
3 |
p. 155-162
8 p.
|
artikel
|
| 62 |
New quantitative enzyme immunoassays for degradation products of fibrin and fibrinogen in plasma: A comparison with other laboratory methods
|
Legnani, C.
|
|
1990
|
|
3 |
p. 189-193
5 p.
|
artikel
|
| 63 |
Notice
|
|
|
1995
|
|
3 |
p. 199-
1 p.
|
artikel
|
| 64 |
Notices
|
|
|
1989
|
|
3 |
p. 187-
1 p.
|
artikel
|
| 65 |
Notices
|
|
|
1987
|
|
3 |
p. 201-
1 p.
|
artikel
|
| 66 |
Notices
|
|
|
1988
|
|
3 |
p. 182-
1 p.
|
artikel
|
| 67 |
Notices
|
|
|
1993
|
|
3 |
p. 217-
1 p.
|
artikel
|
| 68 |
[No title]
|
Ludlam, C.A.
|
|
1990
|
|
3 |
p. 195-
1 p.
|
artikel
|
| 69 |
[No title]
|
Davidson, J.F.
|
|
1990
|
|
3 |
p. 195-196
2 p.
|
artikel
|
| 70 |
[No title]
|
Davidson, J.F.
|
|
1990
|
|
3 |
p. 196-
1 p.
|
artikel
|
| 71 |
[No title]
|
Davidson, J.F.
|
|
1990
|
|
3 |
p. 195-
1 p.
|
artikel
|
| 72 |
Pharmacokinetics and biochemical properties of human pro-urokinase variants carrying the deletion in epidermal growth factor-like domain
|
Morita, M.
|
|
1992
|
|
3 |
p. 141-147
7 p.
|
artikel
|
| 73 |
Plasma coagulation, fibrinolysis and (pro)vitamins in those with ischaemic heart disease
|
Hankey, C.R.
|
|
1996
|
|
3 |
p. 193-
1 p.
|
artikel
|
| 74 |
Plasminogen activator activity of human plasma and transformed cells conditioned media: Dependence on divalent cations
|
Barlati, S.
|
|
1987
|
|
3 |
p. 189-194
6 p.
|
artikel
|
| 75 |
Plasminogen activator inhibitor activity in various types of endogenous hypertriglyceridemia
|
Raccah, D.
|
|
1993
|
|
3 |
p. 171-176
6 p.
|
artikel
|
| 76 |
Plasminogen activator inhibitor (PAI-2) in pregnancy plasma and ovarian cysts, studied by zymography after non-denaturing gel electrophoresis
|
Reith, A.
|
|
1989
|
|
3 |
p. 159-163
5 p.
|
artikel
|
| 77 |
Plasminogen activators and plasminogen activator inhibitor (PAI-1) in type II diabetes mellitus
|
Rydzewski, A.
|
|
1990
|
|
3 |
p. 183-188
6 p.
|
artikel
|
| 78 |
Potentiative effect of heparin in thrombolytic therapy of evolving myocardial infarction with natural pro-urokinase
|
Gulba, D.C.
|
|
1989
|
|
3 |
p. 165-173
9 p.
|
artikel
|
| 79 |
Production and characterisation of a set of monoclonal antibodies against tissue-type plasminogen activator (t-PA)
|
Bos, R.
|
|
1992
|
|
3 |
p. 173-182
10 p.
|
artikel
|
| 80 |
Properties of fibrin high-affinity urokinase obtained from urine, and its comparison with urokinase or single chain-urokinase
|
Hayashi, S.
|
|
1988
|
|
3 |
p. 169-173
5 p.
|
artikel
|
| 81 |
Recent literature on fibrinolysis
|
|
|
1995
|
|
3 |
p. B7-
1 p.
|
artikel
|
| 82 |
Recent literature on fibrinolysis
|
|
|
1992
|
|
3 |
p. B5-B7
nvt p.
|
artikel
|
| 83 |
Recent literature on fibrinolysis
|
|
|
1991
|
|
3 |
p. B5-B6
nvt p.
|
artikel
|
| 84 |
Recent literature on fibrinolysis
|
|
|
1990
|
|
3 |
p. B4-B5
nvt p.
|
artikel
|
| 85 |
Recent literature on fibrinolysis
|
|
|
1994
|
|
3 |
p. B5-
1 p.
|
artikel
|
| 86 |
Recombinant factor XIII supplemented clots resist lysis by plasmin and leucocyte elastase
|
Edwards, M.W.
|
|
1993
|
|
3 |
p. 211-216
6 p.
|
artikel
|
| 87 |
Reduction of PAI-2 production in cultured human peripheral blood monocytes by estradiol and progesterone-no effect on t-PA, u-PA and PAI-1
|
Kinnby, B.
|
|
1995
|
|
3 |
p. 152-156
5 p.
|
artikel
|
| 88 |
Regulation of plasminogen activator inhibitor activity in endothelial cells by tissue-type plasminogen activator
|
Shi, G.-Y.
|
|
1996
|
|
3 |
p. 183-191
9 p.
|
artikel
|
| 89 |
Regulation of plasminogen activator inhibitor type 1 in cultured smooth muscle cells by interleukin 1α and tumour necrosis factor-α
|
Gallicchio, M.
|
|
1995
|
|
3 |
p. 145-151
7 p.
|
artikel
|
| 90 |
Relation of fibrin and tumour-associated antigens to the spread of ovarian cancer
|
Röbl, M.
|
|
1987
|
|
3 |
p. 143-148
6 p.
|
artikel
|
| 91 |
Route of activation, in vitro, of the factor XII-dependent pathway of fibrinolysis
|
Kluft, C.
|
|
1994
|
|
3 |
p. 172-176
5 p.
|
artikel
|
| 92 |
Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators: Demonstration of a promoting effect by t-PA and by platelets on urokinase
|
Gurewich, V.
|
|
1988
|
|
3 |
p. 143-149
7 p.
|
artikel
|
| 93 |
Stabilisation of plasminogen activator inhibitor type 1 (PAI-1) activity by arginine: Possible implications for the interaction of PAI-1 with vitronectin
|
Keijer, J.
|
|
1990
|
|
3 |
p. 153-159
7 p.
|
artikel
|
| 94 |
Staphylokinase, a fibrin-specific bacterial plasminogen activator
|
Lijnen, H.R.
|
|
1996
|
|
3 |
p. 119-126
8 p.
|
artikel
|
| 95 |
Streptokinase-plasmin complex binds to plasminogen receptors on rat hepatocytes and human endothelium
|
Humphries, J.E.
|
|
1991
|
|
3 |
p. 171-176
6 p.
|
artikel
|
| 96 |
Survival of fibrinogen degradation products in the circulation after thrombolytic therapy for acute myocardial infarction
|
Brommer, E.J.P.
|
|
1987
|
|
3 |
p. 149-153
5 p.
|
artikel
|
| 97 |
Synthesis, purification and biological properties of a truncated mutant form of human tissue plasminogen activator produced in E. Coli
|
Fromage, N.
|
|
1991
|
|
3 |
p. 187-190
4 p.
|
artikel
|
| 98 |
The determination of functional plasminogen activator inhibitors (PAI) based on the inhibition of urokinase: PAI normal range and circadian variations in healthy donors; Comparison with other methods
|
Alessi, M.-C.
|
|
1990
|
|
3 |
p. 177-181
5 p.
|
artikel
|
| 99 |
The effect of change in the rhythm of food intake and sleeping time during ramadan on the diurnal variation of fibrinolytic activity
|
Bakir, S.M.
|
|
1991
|
|
3 |
p. 177-180
4 p.
|
artikel
|
| 100 |
The influence of recombinant tissue-type plasminogen activator and plasmin on platelet aggregation: a quenched-flow study
|
Dittmar, S.
|
|
1993
|
|
3 |
p. 158-164
7 p.
|
artikel
|
| 101 |
The protective effect of acylation on the stability of APSAC (eminase) in human plasma
|
Standring, R.
|
|
1988
|
|
3 |
p. 157-163
7 p.
|
artikel
|
| 102 |
The relative inhibition by α2-antiplasmin and plasminogen activator inhibitor-1 of clot lysis in vitro
|
Paramo, J.A.
|
|
1990
|
|
3 |
p. 169-175
7 p.
|
artikel
|
| 103 |
The role of urokinase generation during clot lysis by pro-urokinase in a plasma milieu
|
Giorgetti, C.
|
|
1993
|
|
3 |
p. 183-189
7 p.
|
artikel
|
| 104 |
The selective uptake of high molecular weight urokinase-type plasminogen activator by human platelets
|
Gurewich, V.
|
|
1995
|
|
3 |
p. 188-195
8 p.
|
artikel
|
| 105 |
The synthetic pentasaccharide SR 90107A/org 31540 enhances tissue-type plasminogen activator-induced thrombolysis in rabbits
|
Bernat, A.
|
|
1996
|
|
3 |
p. 151-157
7 p.
|
artikel
|
| 106 |
The typical staccato phenomenon of myoglobin in acute myocardial infarction disappears under thrombolytic treatment
|
Gasser, R.N.A.
|
|
1987
|
|
3 |
p. 177-182
6 p.
|
artikel
|
| 107 |
Thrombolysis with bolus injections and infusions of tissue-type plasminogen activator in rabbits with experimental jugular vein thrombosis
|
Stassen, J.M.
|
|
1991
|
|
3 |
p. 165-170
6 p.
|
artikel
|
| 108 |
Thrombolytic effect of pro-urokinase in vitro
|
Bando, H.
|
|
1987
|
|
3 |
p. 169-176
8 p.
|
artikel
|
| 109 |
Tissue thromboplastin induces rapid inhibition of fibrinolysis in rabbits
|
Filtenborg Tvedskov, T.
|
|
1996
|
|
3 |
p. 143-149
7 p.
|
artikel
|
| 110 |
Urokinase binds to platelets through a specific saturable, low affinity mechanism
|
Vaughan, D.E.
|
|
1990
|
|
3 |
p. 141-146
6 p.
|
artikel
|
| 111 |
Urokinase-producing tumour growth in SCID mice inhibited by recombinant PAI-2
|
Åstedt, B.
|
|
1995
|
|
3 |
p. 175-177
3 p.
|
artikel
|
| 112 |
Utrastructural analysis of thrombolysis by streptokinase and tissue-type plasminogen activator of experimental coronary arterial thrombosis
|
Bugelski, P.J.
|
|
1989
|
|
3 |
p. 137-145
9 p.
|
artikel
|
| 113 |
Vitronectin effects on recombinant plasminogen activator inhibitor-1: structural and functional analysis
|
Reilly, T.M.
|
|
1992
|
|
3 |
p. 167-171
5 p.
|
artikel
|
| 114 |
XIITH International Congress on Fibrinolysis: Invitation from the Chairman
|
|
|
1994
|
|
3 |
p. 201-
1 p.
|
artikel
|
Tijdschrift beschrijving